Using risk factors to predict human papillomavirus infection: Implications for targeted vaccination strategies in young adult women

被引:17
作者
Dempsey, Amanda F. [1 ]
Gebremariam, Achamyeleh [1 ]
Koutsky, Laura A. [2 ]
Manhart, Lisa [3 ]
机构
[1] Univ Michigan, Dept Pediat, Child Hlth Evaluat & Res Unit, Ann Arbor, MI 48109 USA
[2] Univ Washington, UW HPV Res Grp, Dept Epidemiol, Seattle, WA 98103 USA
[3] Univ Washington, UW Ctr AIDS & STD, Dept Epidemiol, Seattle, WA 98104 USA
关键词
human papillomavirus; vaccines; risk factors;
D O I
10.1016/j.vaccine.2007.11.088
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Targeting human papillomavirus (HPV) vaccines to sub-populations most likely to benefit could be necessary if sufficient financing is not available for comprehensive immunization. Using data from 3276 sexually active young adult women in Wave III of the National Longitudinal. Study of Adolescent Health, we investigated the feasibility of using behavioral risk factors to target sub-populations for HPV vaccination. We found associations between specific risk factors and vaccine-type-specific HPV infection (OR 1.7-2.1), and the likelihood of having HPV increased with increasing numbers of risk factors. However, no threshold number of risk factors predicted HPV infection with adequate specificity and sensitivity. Furthermore, at a population level, our analyses indicated that targeted approaches to HPV vaccination using specific risk factors were a poor strategy for vaccine implementation as they would exclude up to 80% of the otherwise eligible population from vaccination. Our results support implementation of comprehensive HPV vaccination strategies. (c) 2007 Elsevier Ltd. All rights reserved.
引用
收藏
页码:1111 / 1117
页数:7
相关论文
共 25 条
[1]  
*ADD HLTH BIOM TEA, 2003, BIOM WAV ALL ADD HLT
[2]  
BROWN D, 2007, 47 INT C ANT AG CHEM
[3]   A longitudinal study of genital human papillomavirus infection in a cohort of closely followed adolescent women [J].
Brown, DR ;
Shew, ML ;
Qadadri, B ;
Neptune, N ;
Vargas, M ;
Tu, WZ ;
Juliar, BE ;
Breen, TE ;
Fortenberry, JD .
JOURNAL OF INFECTIOUS DISEASES, 2005, 191 (02) :182-192
[4]   Sexual behavior and partner characteristics are the predominant risk factors for genital human papillomavirus infection in young women [J].
Burk, RD ;
Ho, GYF ;
Beardsley, L ;
Lempa, M ;
Peters, M ;
Bierman, R .
JOURNAL OF INFECTIOUS DISEASES, 1996, 174 (04) :679-689
[5]  
Carolina Population Center & University of North Carolina Chapel Hill, 1998, NATL LONGITUDINAL ST
[6]  
*CDC, 2007, VFC VACC PRIC LIST
[7]  
Collins S., 2019, COMMONWEALTH FUND
[8]   HUMAN PAPILLOMAVIRUS DNA IN URINE SAMPLES COMPARED WITH THAT IN SIMULTANEOUSLY COLLECTED URETHRA AND CERVIX SAMPLES [J].
FORSLUND, O ;
HANSSON, BG ;
RYMARK, P ;
BJERRE, B .
JOURNAL OF CLINICAL MICROBIOLOGY, 1993, 31 (08) :1975-1979
[9]   Sustained efficacy up to 4-5 years of a bivalent L1 virus-like particle vaccine against human papillomavirus types 16 and 18: follow-up from a randomised control trial [J].
Harper, DM ;
Franco, EL ;
Wheeler, CM ;
Moscicki, AB ;
Romonowski, B ;
Roteli-Martins, CM ;
Jenkins, D ;
Schuind, A ;
Clemens, SAC ;
Dubin, G .
LANCET, 2006, 367 (9518) :1247-1255
[10]   Effect of human papillomavirus 16/18 L1 viruslike particle vaccine among young women with preexisting infection - A randomized trial [J].
Hildesheim, Allan ;
Herrero, Rolando ;
Wacholder, Sholom ;
Rodriguez, Ana C. ;
Solomon, Diane ;
Bratti, M. Concepcion ;
Schiller, John T. ;
Gonzalez, Paula ;
Dubin, Gary ;
Porras, Carolina ;
Jimenez, Silvia E. ;
Lowy, Douglas R. .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2007, 298 (07) :743-753